Traphaco Overview

  • Founded
  • 1972

Founded
  • Status
  • Public

  • Employees
  • 1,476

Employees
  • Stock Symbol
  • TRA

Stock Symbol
  • Share Price
  • $3.92

  • (As of Friday Closing)

Traphaco General Information

Description

Traphaco JSC is engaged in the manufacturing and trading of pharmaceutical products, chemicals and medical supplies and equipment. The company's products include abfuco; amorvita multi; ampelop; aspirin; cagu and amongst others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
STC
Primary Office
  • 75 Yen Ninh
  • Ba Dinh, Ha Noi
  • Hanoi, Ba Dinh
  • Vietnam

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Traphaco Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.92 $3.78 $3.42 - $4.24 $158M 41.5M 1.69K $0.25

Traphaco Financials Summary

In Thousands,
USD
TTM 31-Mar-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 143,637 137,064 157,257 123,539
Revenue 101,387 102,463 92,964 80,978
EBITDA 18,119 18,736 17,665 15,003
Net Income 10,978 11,496 10,394 8,306
Total Assets 78,199 76,764 74,955 70,657
Total Debt 0 1,691 1,179 3,381
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Traphaco Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Traphaco‘s full profile, request access.

Request a free trial

Traphaco Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Traphaco JSC is engaged in the manufacturing and trading of pharmaceutical products, chemicals and medical supplies and
Drug Discovery
Hanoi, Vietnam
1,476 As of 2022
000
00000000000 000

000000

in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
000000000000000
Cao Lanh, Vietnam
0000 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Traphaco Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000000 Corporation Cao Lanh, Vietnam 0000 000.00 00000000000 000.00
You’re viewing 1 of 1 competitors. Get the full list »

Traphaco Executive Team (2)

Name Title Board Seat Contact Info
Tran Tuc Ma Chief Executive Officer
Dinh Kien Chief Accountant
To view Traphaco’s complete executive team members history, request access »

Traphaco Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Traphaco Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Traphaco‘s full profile, request access.

Request a free trial

Traphaco ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Traphaco’s complete esg history, request access »